O. Zaegel-Faucher

发表

Risk factors associated with overweight and obesity in HIV-infected people

S. Brégigeon, I. Poizot-Martin, C. Lions, 2018, Medicine.

A Case of Undiagnosed HIV Infection in a 57-Year-Old Woman with Multiple Myeloma: Consequences on Chemotherapy Efficiency and Safety

R. Bouabdallah, C. Solas, S. Brégigeon, 2016, Case reports in oncological medicine.

Spectrum and Incidence Trends of AIDS- and Non–AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS Cohort

S. Brégigeon, P. Delobel, A. Frésard, 2020, Cancer Epidemiology, Biomarkers & Prevention.

Frailty in HIV infected people: a new risk factor for bone mineral density loss

A. Galinier, S. Brégigeon, I. Poizot-Martin, 2017, AIDS.

Cannabis Use as a Protective Factor Against Overweight in HIV-Hepatitis C Virus Co-Infected People (ANRS CO13 HEPAVIH Cohort).

C. Protopopescu, T. Barré, P. Carrieri, 2022, AIDS education and prevention : official publication of the International Society for AIDS Education.

Sub-therapeutic darunavir concentration and garlic consumption; a «Mediterranean» drug-food interaction, about 2 cases

C. Solas, S. Brégigeon, I. Poizot-Martin, 2017, European Journal of Clinical Pharmacology.

Mandibular osteonecrosis and dental exfoliation after trigeminal zoster in an HIV-infected patient: case report and review of the literature.

S. Brégigeon, C. Chossegros, I. Poizot-Martin, 2014, AIDS.

Microelimination or not? The changing epidemiology of HIV-HCV coinfection in France 2012-2018.

C. Charpentier, R. Tubiana, C. Katlama, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy

S. Brégigeon, C. Tamalet, F. Dignat-George, 2015, AIDS.

Hepatitis C virus-microelimination program and patient trajectories after hepatitis C virus cure in an outpatient HIV clinical unit

P. Carrieri, C. Solas, S. Brégigeon, 2019, European journal of gastroenterology & hepatology.

Multimorbidity in Elderly Subjects according to the year of diagnosis of HIV-Infection - A Cross-Sectional DATAIDS Cohort Study.

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Brief Report: Frailty in Aging People Living With HIV: A Matched Controlled Study

M. Zins, C. Berr, A. Ozguler, 2021, Journal of acquired immune deficiency syndromes.

Dramatic decline in new HIV diagnoses in persons born in France in a large nationwide HIV cohort.

C. Delpierre, F. Raffi, L. Cotte, 2021, Public health.

Unsupervised PrEP in routine practice: a new challenge?

C. Tamalet, I. Poizot-Martin, C. Lions, 2019, International journal of STD & AIDS.

Extracellular vesicles from T cells overexpress miR-146b-5p in HIV-1 infection and repress endothelial activation

J. Micallef, F. Dignat-George, I. Poizot-Martin, 2019, Scientific Reports.

Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2018, The Journal of antimicrobial chemotherapy.

HIV infection and care pathway: From guidelines to clinical practice.

S. Brégigeon, I. Poizot-Martin, C. Lions, 2019, Medecine et maladies infectieuses.

Emergence of uncommon HIV‐1 non‐B subtypes and circulating recombinant forms and trends in transmission of antiretroviral drug resistance in patients with primary infection during the 2013‐2015 period in Marseille, Southeastern France

P. Brouqui, A. Stein, P. Colson, 2018, Journal of medical virology.

Extracellular vesicles from T cells overexpress miR-146b-5p in HIV-1 infection and repress endothelial activation

J. Micallef, F. Dignat-George, I. Poizot-Martin, 2019, Scientific Reports.

Increased Prevalence of Neurocognitive Impairment in Aging People Living With Human Immunodeficiency Virus: The ANRS EP58 HAND 55-70 Study.

M. Zins, C. Berr, E. Thouvenot, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Progressive multifocal leukoencephalopathy in patients with immunovirological control and at least 6 months of combination antiretroviral therapy

G. Martin-Blondel, L. Cotte, M. Valantin, 2021, AIDS.

Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

M. Ziol, C. Delaugerre, C. Katlama, 2022, JHEP reports : innovation in hepatology.

Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study.

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2020, The Journal of antimicrobial chemotherapy.

Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT’AIDS cohort

C. Charpentier, C. Katlama, Y. Yazdanpanah, 2019, BMC Infectious Diseases.

No barrier to care, yet disparities in the HIV care continuum in France: a nationwide population study.

C. Katlama, Y. Yazdanpanah, E. Delaporte, 2021, Journal of Antimicrobial Chemotherapy.

Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study

L. Assoumou, A. Marcelin, M. Veyri, 2024, Journal for immunotherapy of cancer.